Redox-Responsive and Electrically Neutral PLGA Nanoparticles for siRNA Delivery in Human Cervical Carcinoma Cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Redox-Responsive and Electrically Neutral PLGA Nanoparticles for siRNA Delivery in Human Cervical Carcinoma Cells

Published:2022-01-31 Issue:4 Volume:17 Page:1392-1404
ISSN:1872-5120
Container-title:Journal of Pharmaceutical Innovation
language:en
Short-container-title:J Pharm Innov

Author:

Zheng Xiaoling,Zhu Yao,Fei Weidong,Zhao Yunchun,Liu Yunxi,Yan Jingjing,Chen Yue,Zheng Caihong,Zhang Meng

Publisher

Springer Science and Business Media LLC

Subject

Drug Discovery,Pharmaceutical Science

Link

https://link.springer.com/content/pdf/10.1007/s12247-021-09592-z.pdf

Reference31 articles.

1. Itani R, Tobaiqy M, Al FA. Optimizing use of theranostic nanoparticles as a life-saving strategy for treating COVID-19 patients. Theranostics. 2020;10(13):5932–42.

2. Christopher Boyd A, Guo S, Huang L, Kerem B, Oren YS, Walker AJ, et al. New approaches to genetic therapies for cystic fibrosis. J Cyst Fibros. 2020;19(Suppl 1):S54–9.

3. Scherman D, Rousseau A, Bigey P, Escriou V. Genetic pharmacology: progresses in siRNA delivery and therapeutic applications. Gene Ther. 2017;24(3):151–6.

4. Rosa J, Suzuki I, Kravicz M, Caron A, Pupo AV, Praça FG, et al. Current non-viral siRNA delivery systems as a promising treatment of skin diseases. Curr Pharm Des. 2018;24(23):2644–63.

5. Morita Y, Leslie M, Kameyama H, Volk DE, Tanaka T. Aptamer therapeutics in cancer: current and future. Cancers (Basel). 2018;10(3):80.

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HER2 siRNA Facilitated Gene Silencing Coupled with Doxorubicin Delivery: A Dual Responsive Nanoplatform Abrogates Breast Cancer;ACS Applied Materials & Interfaces;2024-05-13

2. Chitosan-based nanosystems for cancer diagnosis and therapy: Stimuli-responsive, immune response, and clinical studies;Carbohydrate Polymers;2024-04

3. Chitosan nanoparticles for gene delivery in cancer therapy and disease diagnosis;Cancer Therapy;2024

4. Development, Optimization, and Evaluation of Nano-platforms for Delivery of siRNA and BPTES in c-Myc Induced Breast Cancer;Journal of Pharmaceutical Innovation;2023-10-31

5. Advance in Nanomedicine for Improving Mucosal Penetration and Effective Therapy of Cervical Cancer;Small;2023-06-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3